These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antimicrobial drug use monitoring by a hospital pharmacy. Greenlaw CW Am J Hosp Pharm; 1977 Aug; 34(8):835-8. PubMed ID: 900135 [TBL] [Abstract][Full Text] [Related]
10. Compliance with a restricted antimicrobial agent policy in a university hospital. Volger BW; Ross MB; Brunetti HR; Baumgartner DD; Therasse DG Am J Hosp Pharm; 1988 Jul; 45(7):1540-4. PubMed ID: 3046348 [TBL] [Abstract][Full Text] [Related]
11. Patient-teaching program for home intravenous antimicrobial therapy. Schad RF; Lucarotti RL Am J Hosp Pharm; 1986 Feb; 43(2):372-5. PubMed ID: 3953598 [TBL] [Abstract][Full Text] [Related]
12. Computer-assisted antimicrobial surveillance in a community teaching hospital. Jozefiak ET; Lewicki JE; Kozinn WP Am J Health Syst Pharm; 1995 Jul; 52(14):1536-40. PubMed ID: 7552895 [TBL] [Abstract][Full Text] [Related]
13. Association of length of stay and total hospital charges with antimicrobial regimen changes. Raisch DW; Bootman JL; McGhan WF Am J Hosp Pharm; 1988 Apr; 45(4):819-23. PubMed ID: 3132038 [TBL] [Abstract][Full Text] [Related]
14. Pharmacy-laboratory interactions: a unique method to control antibiotic costs. Goff D; Thornton J Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600 [TBL] [Abstract][Full Text] [Related]
15. Intravenous metronidazole: a drug utilization review in a community hospital. Nessim D Can J Hosp Pharm; 1987 Feb; 40(1):6-11. PubMed ID: 10281259 [TBL] [Abstract][Full Text] [Related]
16. Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience. Arnold FW; Patel A; Nakamatsu R; Smith RS; Newman D; Sciortino CV; Peyrani P; Snyder J; Schulz P; Ramirez JA J Ky Med Assoc; 2007 Sep; 105(9):431-7. PubMed ID: 17941421 [TBL] [Abstract][Full Text] [Related]
17. Ongoing drug-use review through surveillance of serum antimicrobial-drug concentrations. Illsley SS Am J Hosp Pharm; 1988 Nov; 45(11):2380-1. PubMed ID: 3228097 [No Abstract] [Full Text] [Related]
18. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy. Pastel DA; Chang S; Nessim S; Shane R; Morgan MA Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188 [TBL] [Abstract][Full Text] [Related]
19. Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions. Franson TR; DaMert GJ; Sheth NK; Wisniewski T; Cooper JE; Johnson R; Babcock JB; Hoffmann RG; Malangoni MA Am J Hosp Pharm; 1987 Jan; 44(1):95-101. PubMed ID: 3826095 [TBL] [Abstract][Full Text] [Related]
20. [Selection of appropriate antimicrobial agents to test and report by clinical microbiology laboratories]. Koibuchi H; Shibuya Y; Kubo N; Kawano M; Itoh K Rinsho Byori; 2002 Oct; 50(10):992-9. PubMed ID: 12451681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]